Press Releases
Feb. 13, 2026
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Fighting fraud, saving time, cutting costs: Governor Newsom’s efficiency strategies are improving state government
Gov't Institution
Office of the California Governor
Owner: American Government
Feb. 13, 2026
vTv Therapeutics to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
UGH Entertainment Routes Creator IP Through Concept to Comic™, Turning Novels and Game Worlds Into Comics
Neutral
EIN Presswire
Feb. 11, 2026
fluidIQ’s HOPE inVent™ Miniature In-Line Resuscitator Featured in Images in Anesthesiology
Neutral
EIN Presswire
Feb. 9, 2026
'Contours Of Her Soul' Explores Love, Memory, And Destiny Beyond The Boundaries Of Reality
Neutral
EIN Presswire
Feb. 9, 2026
Amy Crider Marks Mental Health Awareness Month With Memoir Catching an Orange, Releasing April 2026
Neutral
EIN Presswire
Feb. 12, 2026
Aardvark Therapeutics Announces Leadership Appointments
Indeterminate
GlobeNewswire, Inc.
Feb. 10, 2026
Fluidx IDE Trial Results Accepted for Late-Breaking Presentation at the SIR Annual Meeting
Neutral
EIN Presswire
Feb. 5, 2026
How the Story Behind Valentine’s Day Is Resonating With Modern-Day Audiences
Neutral
EIN Presswire
Feb. 13, 2026
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Medicenna Announces Changes to Board Composition
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
Fifteen-Year-Old Clarisa Faces A Challenge of Life and Faith and Finds Strength
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire, Inc.